METABOLON @
European Stroke Organisation Conference
(ESOC) 2024
- Basel, Switzerland
- Booth B17
- May 15 - May 17, 2024
Metabolon is pleased to exhibit at the European Stroke Organisation Conference (ESOC) 2024.
We’re thrilled to announce our participation in the European Stroke Organisation Conference (ESOC) 2024, taking place in Basel, Switzerland. The European Stroke Organisation (ESO) is a pan-European society of stroke researchers and physicians, national and regional stroke societies. The aim of the ESO is to reduce the burden of stroke by changing the way that stroke is viewed and treated, which can only be achieved by professional and public education, and by making institutional changes.
Stroke is a complex neurological condition with diverse metabolic implications. At Metabolon, we specialize in identifying metabolic biomarkers associated with stroke and other neurological disorders. Visit our booth to learn how our metabolomics services can accelerate biomarker discovery and improve patient outcomes. Whether you’re a clinician, researcher, or industry professional, we invite you to join us on the forefront of metabolomics innovation.
For more event information, you can read visit the official event website or read the official program.
Join us at Booth B17
Don’t miss the opportunity to connect with Metabolon at ESOC 2024 in Basel, Switzerland. Stop by booth B17 to meet our team, explore our metabolomics solutions, and discover how we can propel your research forward. Schedule a meeting here to guarantee 1:1 time with a metabolomics expert.
Event Location
Congress Center Basel
Messepl. 21,
4058 Basel,
Switzerland
Google Maps
Why Metabolomics: Your Guide to Metabolomics
In this guide, we explore the ins and outs of one of the most powerful omics tools in any scientist’s toolbox, one that can complement any existing workflow and help realize the full potential of other omics methods: metabolomics.
Schedule a Meeting
Meet the Reps Attending ESOC 2024
Antoine Briffaux
Director, International Sales & Strategic Accounts
Antoine Briffaux serves as the Director of International Sales & Strategic Accounts at Metabolon, overseeing the commercial operations in Europe and Asia and managing partnerships within the BioPharma sector. He holds an MBA from the ULB Solvay Brussels School of Economics & Management, alongside a BSc/MSc in Biology and Psychology from the Free University of Brussels (VUB).
Before his current role at Metabolon, Antoine was the Global Head of Sales at HistoGeneX, a service laboratory specializing in histopathology and genomics. Additionally, he led Global Project Management at SGS Life Sciences, where he was responsible for overseeing clinical trial operations across the company’s global network. His extensive background in biopharmaceutical services and international business strategy has equipped him with a unique blend of scientific expertise and commercial acumen.
Natasa Giallourou
Field Metabolomics Specialist
Dr Natasa Giallourou is a Field Metabolomics Scientist supporting Metabolon’s International Business activities. She provides scientific counsel for metabolomics applications in the biopharma and academic sectors. Natasa obtained her PhD in Metabolomics from the University of Reading and holds an MSc in Nutrition and Health from Wageningen University and a BSc in Biology from the University of Leeds.
Prior to joining Metabolon, Natasa served as a Marie Skłodowska-Curie Postdoctoral Fellow at biobank.cy. Her research projects involved integrating metabolomic data with other ‘omics’ data in population-based studies, with a focus on identifying biomarkers for complex diseases. She has also worked as a Postdoctoral Research Associate at Imperial College London, where she specialized in utilizing metabolic phenotyping to address global health challenges, particularly in the field of public health nutrition.
Natasa sits on the Board of Directors of the International Metabolomics Society and is also an advisor to the Early-career Member’s Network for young metabolomics scientists.
Raffy Demirdjian
Business Development Director
Raffy Demirdjian is a seasoned sales professional with a passion for innovation and leadership in the Life Sciences and Biotechnology field. Specializing in metabolomics and various omics, Raffy is dedicated to assisting clients in finding optimal solutions and advancing their projects in this rapidly evolving field.
With a solid background in academic research and hands-on experience in R&D within the industry, Raffy brings a wealth of knowledge and expertise to every project. His proactive approach and responsiveness ensure that clients receive tailored, high-quality solutions that align perfectly with their R&D objectives.
Based in the Paris region, and covering France and Belgium, Raffy is eager to engage with clients face to face, providing personalized consultations to discuss and strategize metabolomics projects. His commitment to excellence and customer satisfaction makes him a trusted partner for organizations seeking to excel in the realm of life sciences research and development.
